U.S. Markets closed

Here is What Hedge Funds Think About TE Connectivity Ltd. (TEL)

Abigail Fisher

It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund losing about 1%. The Russell 2000, composed of smaller companies, performed even worse, trailing the S&P by more than 6 percentage points, as investors fled less-known quantities for safe havens. Luckily hedge funds were shifting their holdings into large-cap stocks. The 20 most popular hedge fund stocks actually generated an average return of 18.7% so far in 2019 and outperformed the S&P 500 ETF by 6.6 percentage points. We are done processing the latest 13f filings and in this article we will study how hedge fund sentiment towards TE Connectivity Ltd. (NYSE:TEL) changed during the first quarter.

TE Connectivity Ltd. (NYSE:TEL) investors should be aware of an increase in support from the world's most elite money managers of late. TEL was in 26 hedge funds' portfolios at the end of the first quarter of 2019. There were 25 hedge funds in our database with TEL positions at the end of the previous quarter. Our calculations also showed that TEL isn't among the 30 most popular stocks among hedge funds.

According to most investors, hedge funds are assumed to be slow, outdated financial vehicles of the past. While there are over 8000 funds in operation at present, We look at the bigwigs of this group, approximately 750 funds. Most estimates calculate that this group of people shepherd bulk of the smart money's total asset base, and by keeping track of their finest stock picks, Insider Monkey has determined a number of investment strategies that have historically outpaced Mr. Market. Insider Monkey's flagship hedge fund strategy exceeded the S&P 500 index by around 5 percentage points a year since its inception in May 2014 through the end of May. We were able to generate large returns even by identifying short candidates. Our portfolio of short stocks lost 30.9% since February 2017 (through May 30th) even though the market was up nearly 24% during the same period. We just shared a list of 5 short targets in our latest quarterly update and they are already down an average of 11.9% in less than a couple of weeks whereas our long picks outperformed the market by 2 percentage points in this volatile 2 week period.

Bernard Lambilliotte - Ecofin

Let's view the key hedge fund action regarding TE Connectivity Ltd. (NYSE:TEL).

How are hedge funds trading TE Connectivity Ltd. (NYSE:TEL)?

At the end of the first quarter, a total of 26 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 4% from the previous quarter. By comparison, 33 hedge funds held shares or bullish call options in TEL a year ago. With the smart money's capital changing hands, there exists an "upper tier" of noteworthy hedge fund managers who were upping their stakes significantly (or already accumulated large positions).

TEL_june2019

Among these funds, Generation Investment Management held the most valuable stake in TE Connectivity Ltd. (NYSE:TEL), which was worth $370 million at the end of the first quarter. On the second spot was First Pacific Advisors LLC which amassed $356.7 million worth of shares. Moreover, Impax Asset Management, AQR Capital Management, and Citadel Investment Group were also bullish on TE Connectivity Ltd. (NYSE:TEL), allocating a large percentage of their portfolios to this stock.

As aggregate interest increased, key hedge funds have jumped into TE Connectivity Ltd. (NYSE:TEL) headfirst. Citadel Investment Group, managed by Ken Griffin, created the most outsized position in TE Connectivity Ltd. (NYSE:TEL). Citadel Investment Group had $87 million invested in the company at the end of the quarter. Barry Lebovits and Joshua Kuntz's Rivulet Capital also initiated a $69.3 million position during the quarter. The other funds with new positions in the stock are Bernard Lambilliotte's Ecofin Ltd, Minhua Zhang's Weld Capital Management, and Michael Gelband's ExodusPoint Capital.

Let's now review hedge fund activity in other stocks similar to TE Connectivity Ltd. (NYSE:TEL). These stocks are Consolidated Edison, Inc. (NYSE:ED), Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK), Atlassian Corporation Plc (NASDAQ:TEAM), and Sirius XM Holdings Inc (NASDAQ:SIRI). This group of stocks' market values are closest to TEL's market value.

[table] Ticker, No of HFs with positions, Total Value of HF Positions (x1000), Change in HF Position ED,23,1182957,0 TLK,9,134035,3 TEAM,36,1618697,2 SIRI,32,1585774,11 Average,25,1130366,4 [/table]

View table here if you experience formatting issues.

As you can see these stocks had an average of 25 hedge funds with bullish positions and the average amount invested in these stocks was $1130 million. That figure was $1247 million in TEL's case. Atlassian Corporation Plc (NASDAQ:TEAM) is the most popular stock in this table. On the other hand Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) is the least popular one with only 9 bullish hedge fund positions. TE Connectivity Ltd. (NYSE:TEL) is not the most popular stock in this group but hedge fund interest is still above average. Our calculations showed that top 20 most popular stocks among hedge funds returned 1.9% in Q2 through May 30th and outperformed the S&P 500 ETF (SPY) by more than 3 percentage points. Hedge funds were also right about betting on TEL as the stock returned 8.1% during the same period and outperformed the market by an even larger margin. Hedge funds were rewarded for their relative bullishness.

Disclosure: None. This article was originally published at Insider Monkey.

Related Content

  • What You Should Know About Unique Fabricating, Inc.'s (NYSEMKT:UFAB) Financial Strength
    Business
    Simply Wall St.

    What You Should Know About Unique Fabricating, Inc.'s (NYSEMKT:UFAB) Financial Strength

    At this current level of debt, the current cash and short-term investment levels stands at US$1.3m , ready to be used for running the business. Moreover, UFAB has generated US$9.5m in operating cash flow in the last twelve months, resulting in an operating cash to total debt ratio of 17%, meaning that UFAB's debt is not covered by operating cash. Can UFAB meet its short-term obligations with the cash in hand?

  • Chipotle sales beat expectations, stock jumps
    Business
    Yahoo Finance

    Chipotle sales beat expectations, stock jumps

    Chipotle's (CMG) second-quarter sales smashed expectations, the stock soared 5% in after-hours trade. Here are the numbers for Chipotle's second quarter, based on Wall Street analyst expectations: Revenue: $1.43 billion vs. $1.41 billion expected Adj. earnings per share: $3.99 vs. $3.76 expected Same-store sales: +10% vs. +8.4% expected The burrito giant has been crushing it recently.

  • Does The Marcus Corporation's (NYSE:MCS) CEO Pay Compare Well With Peers?
    Business
    Simply Wall St.

    Does The Marcus Corporation's (NYSE:MCS) CEO Pay Compare Well With Peers?

    Greg Marcus became the CEO of The Marcus Corporation (NYSE:MCS) in 2009. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. At the time of writing our data says that The Marcus Corporation has a market cap of US$995m, and is paying total annual CEO compensation of US$2.9m.

  • Should Core-Mark Holding Company, Inc. (NASDAQ:CORE) Be Part Of Your Dividend Portfolio?
    Business
    Simply Wall St.

    Should Core-Mark Holding Company, Inc. (NASDAQ:CORE) Be Part Of Your Dividend Portfolio?

    Is Core-Mark Holding Company, Inc. (NASDAQ:CORE) a good dividend stock? Dividend paying companies with growing earnings can be highly rewarding in the long term. Unfortunately, it's common for investors to be enticed in by the seemingly attractive yield, and lose money when the company has to cut its dividend payments.

  • Texas Instruments Stock Surges On Second-Quarter Earnings Beat
    Business
    Investor's Business Daily

    Texas Instruments Stock Surges On Second-Quarter Earnings Beat

    Chipmaker Texas Instruments Tuesday beat Wall Street's sales and earnings targets for the second quarter. The Texas Instruments earnings news sent its stock higher in extended trading. TXN stock is near a record high.

  • Beyond Meat Soars Above $200 as Pre-Earnings Bid Continues
    Business
    Bloomberg

    Beyond Meat Soars Above $200 as Pre-Earnings Bid Continues

    Investors are eagerly awaiting second-quarter earnings next week for further clues on demand for alternative meat products. JPMorgan analyst Ken Goldman, who downgraded the stock to neutral back in June, said an earnings beat is “more likely than the opposite,” recommending in a note last week that his clients own Beyond Meat “for a trade” in the near term. One the stock's first shorts, Harrington Alpha Fund founder Bruce Cox, has capitulated due to “outrageous” borrowing rates, he told Bloomberg in an interview last week.

  • Beyond Meat touches new all-time high ahead of earnings
    Business
    Yahoo Finance Video

    Beyond Meat touches new all-time high ahead of earnings

    Beyond Meat touched an all-time high this morning of just over $208 per share. The alternative meat company is set to report second quarter earnings next week. Yahoo Finance's Zack Guzman and Heidi Chung are joined by Anna-Marie Wascher, Flat World Partners CEO, to discuss.

  • 3 Charts That Suggest Gold Is Going Higher
    Business
    Investopedia

    3 Charts That Suggest Gold Is Going Higher

    From a fundamental perspective, relatively low interest rates across the globe and a heightened risk of geopolitical trade war have acted as catalysts for investors to send prices of gold higher. Over in the world of technical trading, the bullish price action has also caught the attention of active traders because the price of gold has moved out of a horizontal channel pattern that has dominated the momentum of the commodity for most of 2019. As both camps continue to fuel the upward momentum, the gains will likely start to capture the attention of the media outlets, which in turn will cause new investors to take another look at gold and spark an even strong move higher.

  • Business
    Reuters

    Catalyst Capital seeks to take Hudson's Bay stake to oppose chairman's offer to go private

    Private equity firm Catalyst Capital Group Inc on Monday offered to buy an estimated C$150 million stake in Hudson's Bay Co , and said it will oppose Executive Chairman Richard Baker's C$1.74 billion take-private proposal. A shareholder group led by Baker, which collectively owns a 57% stake in Hudson's Bay, had made an offer of C$9.45 per share to take the struggling retailer private in June, with plans to fund the deal using some of the proceeds from asset sales. Catalyst, run by Canadian financier Newton Glassman, on Monday offered to buy up to 14.85 million shares of Hudson's Bay at C$10.11 per share, saying it believes Baker's proposal "greatly undervalues the company."

  • Here's Why We Think Aircastle (NYSE:AYR) Is Well Worth Watching
    Business
    Simply Wall St.

    Here's Why We Think Aircastle (NYSE:AYR) Is Well Worth Watching

    So if you're like me, you might be more interested in profitable, growing companies, like Aircastle (NYSE:AYR). While profit is not necessarily a social good, it's easy to admire a business than can consistently produce it. In comparison, loss making companies act like a sponge for capital - but unlike such a sponge they do not always produce something when squeezed.

  • Here's Why Marinus Pharmaceuticals Stock Is Collapsing Today
    Business
    Motley Fool

    Here's Why Marinus Pharmaceuticals Stock Is Collapsing Today

    What happened Shares of Marinus Pharmaceuticals (NASDAQ: MRNS) fell over 70% today after the company announced results from an important midstage clinical trial for its only drug candidate, ganaxolone. The experimental therapy was administered to women with postpartum depression as a six-hour infusion followed by an oral dose. That approach led to what the company called a "clinically meaningful" reduction as measured by the Hamilton Rating Scale for Depression after six hours and 24 hours.

  • How Many Universal Corporation (NYSE:UVV) Shares Have Insiders Sold, In The Last Year?
    Business
    Simply Wall St.

    How Many Universal Corporation (NYSE:UVV) Shares Have Insiders Sold, In The Last Year?

    So before you buy or sell Universal Corporation (NYSE:UVV), you may well want to know whether insiders have been buying or selling. What Is Insider Buying? Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock on the market.

  • Chipotle Earnings, Sales Growth To Slow With Tough Comparisons Ahead
    Business
    Investor's Business Daily

    Chipotle Earnings, Sales Growth To Slow With Tough Comparisons Ahead

    Chipotle Earnings Estimates: Wall Street expects a 29% jump in Chipotle earnings per share to $3.69, after EPS surged 60% in Q1. Revenue is expected to increase 11% to $1.405 billion, cooling off after four consecutive quarters of faster growth. Consensus Metrix forecasts an 8.4% gain in same-store sales, or sales at restaurants open at least a year.

  • Curaleaf tumbles on FDA's CBD marketing crackdown
    Business
    Yahoo Finance Video

    Curaleaf tumbles on FDA's CBD marketing crackdown

    Curaleaf tumbled today after the FDA issued a warning to the company on its marketing efforts for its CBD oil, saying the company was making unsubstantiated health claims. Yahoo Finance's Zack Guzman and Heidi Chung are joined by Anna-Marie Wascher, Flat World Partners CEO, to discuss.

  • Why Acadia Pharmaceuticals Is Tanking Today
    Business
    Motley Fool

    Why Acadia Pharmaceuticals Is Tanking Today

    Shares of Acadia Pharmaceuticals (NASDAQ: ACAD), a mid-cap biopharma focused on diseases of the central nervous system, had fallen 14% as of 11:01 a.m. EST on Tuesday. The sell-off is traceable to the release of disappointing phase 3 results from a clinical trial. This trial was designed to test its drug pimavanserin (Nuplazid) as a treatment for schizophrenia patients with persistent inadequate response to their current antipsychotic therapy.

  • ‘Enough is enough’: Warren officially introduces bill to cancel student debt
    Business
    Yahoo Finance

    ‘Enough is enough’: Warren officially introduces bill to cancel student debt

    Warren first pitched a student debt plan as a presidential candidate in April, and then started discussing the upcoming legislation in June. Taken together, Warren's plans attack student debt in three ways: Cancelling debt, reforming the predatory — or “lousy” — student loan system that's in place, and making college free for all. I was shocked when I woke up one morning … and saw that student loan debt had eclipsed credit card debt,” Rep. Clyburn said at a press conference to unveil the legislation.

  • Is Knight Therapeutics Inc. (TSE:GUD) Potentially Underrated?
    Business
    Simply Wall St.

    Is Knight Therapeutics Inc. (TSE:GUD) Potentially Underrated?

    Knight Therapeutics Inc. (TSE:GUD) is a stock with outstanding fundamental characteristics. In the case of GUD, it is a company with strong financial health as well as an optimistic growth outlook. For those interested in digging a bit deeper into my commentary, take a look at the report on Knight Therapeutics here.

  • Cannabis News: Cash Is King
    Business
    Motley Fool

    Cannabis News: Cash Is King

    Many cannabis companies are finding it difficult to raise capital, and it can be challenging for marijuana producers to obtain financing at attractive rates. This is particularly true for smaller growers. Analysts at Stifel Financial recently highlighted these challenges in a research note.

  • Is There Now An Opportunity In Ferrari N.V. (NYSE:RACE)?
    Business
    Simply Wall St.

    Is There Now An Opportunity In Ferrari N.V. (NYSE:RACE)?

    The company's shares led the NYSE gainers with a relatively large price hike in the past couple of weeks. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. Let's take a look at Ferrari's outlook and value based on the most recent financial data to see if the opportunity still exists.

  • Lannett Company (LCI) Stock Makes the Street Go Wild
    Business
    SmarterAnalyst

    Lannett Company (LCI) Stock Makes the Street Go Wild

    Your guess is as good as anybody else's. SunTrust analyst Gregg Gilbert believes "management has been doing the right things to diversify the business and grow out of the levo trough." However, the analyst remains sidelined on the stock "pending greater visibility on the durability and profitability of the evolving portfolio and strategy to deal with the large debt load."

  • Is Slack a Buy?
    Business
    Motley Fool

    Is Slack a Buy?

    Slack stock is still trading above its initial reference price. It's not broken. However, now that the analysts involved in the resale registration have chimed in with their mostly bullish initiations earlier this month, there isn't a lot of institutional ammo to support the investment.

  • Why Polaris Industries Stock Jumped Today
    Business
    Motley Fool

    Why Polaris Industries Stock Jumped Today

    What happened Shares of Polaris Industries (NYSE: PII) were up 10.3% as of 2:50 p.m. EDT Tuesday after the off-road vehicle and motorcycle specialist announced strong quarterly results. More specifically, Polaris' quarterly revenue climbed 18% year over year to $1.779 billion, with adjusted net income of $107.5 million, or $1.73 per share.

  • 3 High-Flying Stocks Fallen on Hard Times
    Business
    Motley Fool

    3 High-Flying Stocks Fallen on Hard Times

    The kind of price drop we saw last year can rattle investors, but the future of Align Technology is still bright. Align is still the clear leader in discrete teeth aligners, with over 5 million patients in 90 different countries. Align Technology has over 400 U.S. patents, a network of doctors, and has even become a household name -- no small feat for an orthodontic company.

  • Looking At Freeport-McMoRan Inc. (NYSE:FCX) From All Angles
    Business
    Simply Wall St.

    Looking At Freeport-McMoRan Inc. (NYSE:FCX) From All Angles

    I've been keeping an eye on Freeport-McMoRan Inc. (NYSE:FCX) because I'm attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe FCX has a lot to offer. If you're interested in understanding beyond my broad commentary, read the full report on Freeport-McMoRan here.

  • Why Karyopharm Therapeutics Is Up Today
    Business
    Motley Fool

    Why Karyopharm Therapeutics Is Up Today

    What happened Shares of Karyopharm Therapeutics (NASDAQ: KPTI), a commercial-stage biopharmaceutical company focused on oncology, rose as much as 10% in early-morning trading on Tuesday. Shares were up about 7% as of 11:45 a.m. EST.